Seo-Woo Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Seo-Woo Park has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Ho Ra
Department of Ophthalmology, Bucheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea
1 shared publication - Jay Chhablani
UPMC Eye Center, University of Pittsburgh, Pittsburgh, Pennsylvania
1 shared publication - Ji Min Kim
Department of Pathology, Ewha Womans University Mokdong Hospital, Ewha Womans University College of Medicine, Seoul, Republic of Korea
1 shared publication - Jin-Ho Joo
Department of Ophthalmology, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Korea
1 shared publication - Jiwon Baek
Department of Ophthalmology, Bucheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Republic of Korea
1 shared publication - Seung Hoon Lee
Department of Ophthalmology, Bucheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, #327 Sosa-ro, Wonmi-gu, Bucheon 14647, Gyeonggi-do, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 19 December 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (51) , e46651
Bilateral endogenous endophthalmitis from asymptomatic Aspergillus niger fungal infective endocarditis in the immunosuppressed patient: A case report
Rationale: Endogenous fungal endophthalmitis (EFE) is a rare but sight- and life-threatening condition that often arises in immunocompromised patients. While Aspergillus fumigatus is the predominant pathogen, Aspergillus niger -associated endocarditis leading to bilateral EFE has not been previously reported. Patient concerns: A 51-year-old woman with a history of two renal transplants over the past 30 years, along with diabetes mellitus, hypertension, and ongoing immunosuppressive therapy, presented with rapidly progressive bilateral visual impairment, beginning with acute vision loss and ocular pain in the right eye, followed by involvement of the left eye within two days. She had no systemic symptoms such as fever, chest pain, or dyspnea. Diagnosis: Initial aqueous humor analysis, including Gram staining, fungal culture, and viral PCR, yielded negative results. As the disease progressed to bilateral involvement within 2 days, a diagnostic vitrectomy was performed. Vitreous sampling demonstrated fungal hyphae, and culture confirmed Aspergillus niger . Transesophageal echocardiography further revealed mitral valve vegetation, establishing the diagnosis of fungal infective endocarditis with bilateral endogenous endophthalmitis. Interventions: The patient received empiric intravitreal antibiotics and antivirals initially, followed by diagnostic pars plana vitrectomy and systemic antifungal therapy after identification of Aspergillus . Mitral valve replacement surgery was subsequently performed. Outcomes: Despite surgical intervention and systemic antifungal treatment, the patient developed disseminated fungal sepsis and died 2 weeks after valve replacement. Lessons: This case highlights the diagnostic challenges of EFE and emphasizes the importance of considering fungal endocarditis as a source of infection in immunosuppressed patients presenting with severe vitritis, even in the absence of systemic symptoms. Early recognition, prompt vitrectomy with intravitreal antifungal therapy, and thorough systemic evaluation are essential to improve visual and systemic outcomes.
- 19 December 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (51) , e46651
Open AccessBilateral endogenous endophthalmitis from asymptomatic Aspergillus niger fungal infective endocarditis in the immunosuppressed patient: A case report
Rationale: Endogenous fungal endophthalmitis (EFE) is a rare but sight- and life-threatening condition that often arises in immunocompromised patients. While Aspergillus fumigatus is the predominant pathogen, Aspergillus niger -associated endocarditis leading to bilateral EFE has not been previously reported. Patient concerns: A 51-year-old woman with a history of two renal transplants over the past 30 years, along with diabetes mellitus, hypertension, and ongoing immunosuppressive therapy, presented with rapidly progressive bilateral visual impairment, beginning with acute vision loss and ocular pain in the right eye, followed by involvement of the left eye within two days. She had no systemic symptoms such as fever, chest pain, or dyspnea. Diagnosis: Initial aqueous humor analysis, including Gram staining, fungal culture, and viral PCR, yielded negative results. As the disease progressed to bilateral involvement within 2 days, a diagnostic vitrectomy was performed. Vitreous sampling demonstrated fungal hyphae, and culture confirmed Aspergillus niger . Transesophageal echocardiography further revealed mitral valve vegetation, establishing the diagnosis of fungal infective endocarditis with bilateral endogenous endophthalmitis. Interventions: The patient received empiric intravitreal antibiotics and antivirals initially, followed by diagnostic pars plana vitrectomy and systemic antifungal therapy after identification of Aspergillus . Mitral valve replacement surgery was subsequently performed. Outcomes: Despite surgical intervention and systemic antifungal treatment, the patient developed disseminated fungal sepsis and died 2 weeks after valve replacement. Lessons: This case highlights the diagnostic challenges of EFE and emphasizes the importance of considering fungal endocarditis as a source of infection in immunosuppressed patients presenting with severe vitritis, even in the absence of systemic symptoms. Early recognition, prompt vitrectomy with intravitreal antifungal therapy, and thorough systemic evaluation are essential to improve visual and systemic outcomes.
- Open Access
- 2 April 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (7) , 754
Quantification of Choroidal Vascular Hyperpermeability on Ultra-Widefield Indocyanine Green Angiography in Macular Neovascularization
To obtain a quantitative parameter for the measurement of choroidal vascular hyperpermeability (CVH) on ultra-widefield indocyanine green angiography (UWICGA) using an objective analysis method in macular choroidal neovascularization (CNV). A total of 113 UWICGA images from 113 subjects were obtained, including with 25 neovascular age-related macular degeneration (nAMD), 37 with polypoidal choroidal vasculopathy (PCV) (19 with thin-choroid and 18 with thick-choroid), 33 with pachychoroid neovasculopathy (PNV), and 18 age-matched controls. CVH was quantified on a gray image by the subtraction of 2 synchronized UWICGA images of early and late phases. The measured CVH parameter was compared with human graders and among CNV subtypes and correlated with choroidal vascular density (CVD) and subfoveal choroidal thickness (SFCT). The mean CVH values were 28.58 ± 4.97, 33.36 ± 8.40, 33.61 ± 11.50, 42.19 ± 13.25, and 43.59 ± 7.86 in controls and patients with nAMD, thin-choroid PCV, thick-choroid PCV, and PNV, respectively (p < 0.001). CVH was higher in thick-choroid PCV and PNV compared to the other groups (all p ≤ 0.006). The measured CVH value positively correlated with those reported by human graders (p < 0.001), CVD, and SFCT (p = 0.001 and p < 0.001, respectively). CVH can be measured objectively using quantitative UWICGA analysis. The CVH parameter differs among macular CNV subtypes and correlates with CVD and SFCT.
- 2 April 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (7) , 754
Open AccessQuantification of Choroidal Vascular Hyperpermeability on Ultra-Widefield Indocyanine Green Angiography in Macular Neovascularization
To obtain a quantitative parameter for the measurement of choroidal vascular hyperpermeability (CVH) on ultra-widefield indocyanine green angiography (UWICGA) using an objective analysis method in macular choroidal neovascularization (CNV). A total of 113 UWICGA images from 113 subjects were obtained, including with 25 neovascular age-related macular degeneration (nAMD), 37 with polypoidal choroidal vasculopathy (PCV) (19 with thin-choroid and 18 with thick-choroid), 33 with pachychoroid neovasculopathy (PNV), and 18 age-matched controls. CVH was quantified on a gray image by the subtraction of 2 synchronized UWICGA images of early and late phases. The measured CVH parameter was compared with human graders and among CNV subtypes and correlated with choroidal vascular density (CVD) and subfoveal choroidal thickness (SFCT). The mean CVH values were 28.58 ± 4.97, 33.36 ± 8.40, 33.61 ± 11.50, 42.19 ± 13.25, and 43.59 ± 7.86 in controls and patients with nAMD, thin-choroid PCV, thick-choroid PCV, and PNV, respectively (p < 0.001). CVH was higher in thick-choroid PCV and PNV compared to the other groups (all p ≤ 0.006). The measured CVH value positively correlated with those reported by human graders (p < 0.001), CVD, and SFCT (p = 0.001 and p < 0.001, respectively). CVH can be measured objectively using quantitative UWICGA analysis. The CVH parameter differs among macular CNV subtypes and correlates with CVD and SFCT.